References
- Cole RR, Myer CM, Cotton RT. Tracheotomy in children with recurrent respiratory papillomatosis. Head Neck. 1989;11(3):226–230.
- Fasunla AJ, Lasisi OA. Diagnostic challenges of laryngeal papillomatosis and its implications among children in developing country. Int J Pediatr Otorhinolaryngol. 2009;73(4):593–595.
- Khan M, Naidu TK. Risk factors associated with severe recurrent respiratory papillomatosis. S Afr J Infect Dis. 2019;34(1):69.
- Niu Z, Xiao Y, Ma L, et al. Tracheotomy as a predictor of remission and demise for juvenile-onset recurrent respiratory papillomatosis. Acta Otolaryngol. 2021;142(1):84–88.
- Soldatski IL, Onufrieva EK, Steklov AM, et al. Tracheal, bronchial, and pulmonary papillomatosis in children. Laryngoscope. 2005;115(10):1848–1854.
- Ivancic R, Iqbal H, deSilva B, et al. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol. 2018;3(1):22–34.
- Shapiro AM, Rimell FL, Shoemaker D, et al. Tracheotomy in children with juvenile-onset recurrent respiratory papillomatosis: the Children's Hospital of Pittsburgh experience. Ann Otol Rhinol Laryngol. 1996;105(1):1–5.
- Yang Q, Li Y, Ma L, et al. Long-term outcomes of juvenile onset recurrent respiratory papillomatosis with pulmonary involvement. Laryngoscope. 2021;131(7):EE2277–E2283.
- Wang J, Han DM, Ma LJ, et al. Risk factors of juvenile onset recurrent respiratory papillomatosis in the lower respiratory tract. Chin Med J. 2012;125(19):3496–3499.
- Scatolini ML, Cocciaglia A, Perez CG, et al. Laryngeal reconstruction in children with recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2018;115:120–124.
- Siegel B, Smith LP. Management of complex glottic stenosis in children with recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2013;77(10):1729–1733.
- Hermann JS, Pontes P, Weckx LL, et al. Laryngeal sequelae of recurrent respiratory papillomatosis surgery in children. Rev Assoc Med Bras. 2012;58(2):204–208.
- Hung WC, Lo WC, Fang KM, et al. Longitudinal voice outcomes following serial potassium titanyl phosphate laser procedures for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 2021;130(4):363–369.
- Zeitels SM, Akst LM, Burns JA, et al. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol. 2006;115(9):679–685.
- Pogoda L, Ziylan F, Smeeing DPJ, et al. Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review. Eur Arch Otorhinolaryngol. 2022.
- Sidell DR, Balakrishnan K, Best SR, et al. Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement. Laryngoscope. 2021;131(6):E1941–e1949.
- Fan S, Li P, Ouyang L, et al. Anal human papillomavirus infection among MSM attending university in China: implications for vaccination. Vaccines. 2020;8(2):175.
- D N, ATL C, Y Z, et al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018;217(2):208–212.
- Makiyama K, Hirai R, Matsuzaki H. Gardasil vaccination for recurrent laryngeal papillomatosis in adult men: first report: changes in HPV antibody titer. J Voice. 2017;31(1):104–106.
- Rosenberg T, Philipsen BB, Mehlum CS, et al. Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis. J Infect Dis. 2019;219(7):1016–1025.